EUVIMEDEUVIMED entdecken
Open Access

ARF alters PAF1 complex integrity to selectively repress oncogenic transcription programs upon p53 loss

Jinli Wang, Nikole L Fendler, Ashutosh Shukla, Shwu-Yuan Wu, Ashwini Challa, Jeon Lee, Lukasz A Joachimiak, John D Minna, Cheng-Ming Chiang, Seychelle M Vos, Iván D'Orso

Molecular Cell · 2024

DOI: 10.1016/j.molcel.2024.10.020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2024. Verfasst von Jinli Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, The University of Texas Southwestern Medical Center, Dallas, TX, USA. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Transcription, Genetic. Die Arbeit nennt 125 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The polymerase associated factor 1 (PAF1) complex (PAF1c) promotes RNA polymerase II (RNA Pol II) transcription at the elongation step; however, how PAF1c transcription activity is selectively regulated during cell fate transitions remains poorly understood. Here, we reveal that the alternative reading frame (ARF) tumor suppressor operates at two levels to restrain PAF1c-dependent oncogenic transcriptional programs upon p53 loss in mouse cells. First, ARF assembles into homo-oligomers to bind the PAF1 subunit to promote PAF1c disassembly, consequently dampening PAF1c interaction with RNA Pol II and PAF1c-dependent transcription. Second, ARF targets the RUNX family transcription factor 1 (RUNX1) to selectively tune gene transcription. Consistently, ARF loss triggers RUNX1- and PAF1c-dependent transcriptional activation of pro-growth ligands (growth differentiation factor/bone morphogenetic protein [GDF/BMP]), promoting a cell-intrinsic GDF/BMP-Smad1/5 axis that aberrantly induce cell growth. Notably, pharmacologic inactivation of GDF/BMP signaling and genetic perturbation of RUNX1 significantly attenuate cell proliferation mediated by dual p53 and ARF loss, offering therapeutic utility. Our data underscore the significance of selective ARF-mediated tumor-suppressive functions through a universal transcriptional regulator.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Transcription, GeneticAnimalsMiceHumansCore Binding Factor Alpha 2 SubunitCell ProliferationRNA Polymerase IISignal TransductionTranscription FactorsCarcinogenesisGene Expression Regulation, NeoplasticNuclear ProteinsHEK293 Cells

Stichwörter der Autor:innen

ARFCDKN2APAF1RNA polymerase IIRUNXcell proliferationp53transcriptiontumor suppressortumorigenesis

Substanzen

Tumor Suppressor Protein p53Core Binding Factor Alpha 2 SubunitTrp53 protein, mouseRunx1 protein, mouseRNA Polymerase IITranscription FactorsPAF1 protein, humanNuclear Proteins

Autor:innen und Institutionen

  • Department of Microbiology, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Massachusetts Institute of Technology, Department of Biology, Cambridge, MA, USA.
  • Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Lydia Hill Department of Bioinformatics, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Department of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr. Brain Institute, The University of Texas South…
  • Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Hamo…

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • NIGMS NIH HHS
  • Cancer Prevention and Research Institute of Texas
  • National Institute of General Medical Sciences
  • National Institute on Aging
  • National Science Foundation Directorate for Biological Sciences
  • National Institutes of Health

Zitieren

APA

Wang, J., Fendler, N. L., Shukla, A., Wu, S. Y., Challa, A., Lee, J., Joachimiak, L. A., Minna, J. D., Chiang, C. M., Vos, S. M., & D'Orso, I. (2024). ARF alters PAF1 complex integrity to selectively repress oncogenic transcription programs upon p53 loss. Molecular Cell. https://doi.org/10.1016/j.molcel.2024.10.020

Vancouver

Wang J, Fendler NL, Shukla A, Wu SY, Challa A, Lee J, et al. ARF alters PAF1 complex integrity to selectively repress oncogenic transcription programs upon p53 loss. Molecular Cell. 2024. doi:10.1016/j.molcel.2024.10.020

BibTeX
@article{Wang2024,
  author = {Wang, Jinli and Fendler, Nikole L and Shukla, Ashutosh and Wu, Shwu-Yuan and Challa, Ashwini and Lee, Jeon and Joachimiak, Lukasz A and Minna, John D and Chiang, Cheng-Ming and Vos, Seychelle M and D'Orso, Iván},
  title = {ARF alters PAF1 complex integrity to selectively repress oncogenic transcription programs upon p53 loss},
  journal = {Molecular Cell},
  year = {2024},
  doi = {10.1016/j.molcel.2024.10.020}
}
Kostenlos starten →